These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9054806)

  • 1. Naltrexone for alcoholic adolescents.
    Lifrak PD; Alterman AI; O'Brien CP; Volpicelli JR
    Am J Psychiatry; 1997 Mar; 154(3):439-41. PubMed ID: 9054806
    [No Abstract]   [Full Text] [Related]  

  • 2. Naltrexone in the treatment of alcoholism: predicting response to naltrexone.
    Volpicelli JR; Clay KL; Watson NT; O'Brien CP
    J Clin Psychiatry; 1995; 56 Suppl 7():39-44. PubMed ID: 7673104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications.
    Namkoong K; Farren CK; O'Connor PG; O'Malley SS
    J Clin Psychiatry; 1999 Jul; 60(7):449-53. PubMed ID: 10453799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
    Krishnan-Sarin S; Krystal JH; Shi J; Pittman B; O'Malley SS
    Biol Psychiatry; 2007 Sep; 62(6):694-7. PubMed ID: 17336941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of naltrexone on alcohol "high" in alcoholics.
    Volpicelli JR; Watson NT; King AC; Sherman CE; O'Brien CP
    Am J Psychiatry; 1995 Apr; 152(4):613-5. PubMed ID: 7694913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone reduces heavy drinking in problem drinkers across the spectrum of dependence.
    Hester RK
    J Clin Psychiatry; 2015 Feb; 76(2):e226-7. PubMed ID: 25742215
    [No Abstract]   [Full Text] [Related]  

  • 7. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
    Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
    Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
    Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
    Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
    Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
    JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience of a "slip" among alcoholics treated with naltrexone or placebo.
    O'Malley SS; Jaffe AJ; Rode S; Rounsaville BJ
    Am J Psychiatry; 1996 Feb; 153(2):281-3. PubMed ID: 8561215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone in the treatment of alcohol dependence.
    Volpicelli JR; Alterman AI; Hayashida M; O'Brien CP
    Arch Gen Psychiatry; 1992 Nov; 49(11):876-80. PubMed ID: 1345133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Holidays, triggers, and willpower--is there a role for medications? A commentary on "The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients".
    Rosenbloom DL
    J Subst Abuse Treat; 2009 Jan; 36(1):7. PubMed ID: 19038694
    [No Abstract]   [Full Text] [Related]  

  • 15. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence.
    O'Malley SS; Jaffe AJ; Chang G; Rode S; Schottenfeld R; Meyer RE; Rounsaville B
    Arch Gen Psychiatry; 1996 Mar; 53(3):217-24. PubMed ID: 8611058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
    O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
    J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential use of naltrexone in the treatment of relapsing alcoholism.
    Farren CK; O'Malley S
    Am J Psychiatry; 1997 May; 154(5):714. PubMed ID: 9137139
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling.
    Toneatto T; Brands B; Selby P
    Am J Addict; 2009; 18(3):219-25. PubMed ID: 19340640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.
    Jaffe AJ; Rounsaville B; Chang G; Schottenfeld RS; Meyer RE; O'Malley SS
    J Consult Clin Psychol; 1996 Oct; 64(5):1044-53. PubMed ID: 8916634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.